Cellectar Biosciences Inc (CLRB)

[Crusader]

Oh 'la 'la...stock has a "shrinkage" proble,

It quickly deflates after each round of conquest!

Today it enjoyed $2.00

Then it shrunk by...15 cents (;
C
It needs constant stimulation.

This must be an old man's stock!

From today's PR

"...To date, the PDC molecules have demonstrated a [color=red]clear cancer targeting advantage[color=red] over the unconjugated payloads," said Jim Caruso, president and CEO of Cellectar Biosciences. "We look forward to leveraging the synergistic technologies and skills of our respective organizations to further advance this exciting research."